WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
German Center for Infection Research (DZIF), Partner Site Hamburg-Luebeck-Borstel-Reims, 38124 Braunschweig, Germany.
Viruses. 2023 Feb 22;15(3):599. doi: 10.3390/v15030599.
Emerging infectious diseases of zoonotic origin are an ever-increasing public health risk and economic burden. The factors that determine if and when an animal virus is able to spill over into the human population with sufficient success to achieve ongoing transmission in humans are complex and dynamic. We are currently unable to fully predict which pathogens may appear in humans, where and with what impact. In this review, we highlight current knowledge of the key host-pathogen interactions known to influence zoonotic spillover potential and transmission in humans, with a particular focus on two important human viruses of zoonotic origin, the Nipah virus and the Ebola virus. Namely, key factors determining spillover potential include cellular and tissue tropism, as well as the virulence and pathogenic characteristics of the pathogen and the capacity of the pathogen to adapt and evolve within a novel host environment. We also detail our emerging understanding of the importance of steric hindrance of host cell factors by viral proteins using a "flytrap"-type mechanism of protein amyloidogenesis that could be crucial in developing future antiviral therapies against emerging pathogens. Finally, we discuss strategies to prepare for and to reduce the frequency of zoonotic spillover occurrences in order to minimize the risk of new outbreaks.
新发传染病的动物源传染病是一个日益严重的公共卫生风险和经济负担。决定动物病毒是否以及何时能够成功溢出到人群中,并在人群中持续传播的因素是复杂和动态的。我们目前无法完全预测哪些病原体可能出现在人类身上,以及会产生什么影响。在这篇综述中,我们重点介绍了目前已知的影响动物源病毒溢出潜力和人类传播的关键宿主-病原体相互作用的知识,特别关注两种重要的动物源人类病毒,即尼帕病毒和埃博拉病毒。即,决定溢出潜力的关键因素包括细胞和组织嗜性,以及病原体的毒力和致病性特征,以及病原体在新宿主环境中适应和进化的能力。我们还详细介绍了我们对病毒蛋白通过“捕蝇草”型蛋白淀粉样形成机制对宿主细胞因子的空间位阻的重要性的认识,这对于开发针对新出现病原体的抗病毒治疗方法可能至关重要。最后,我们讨论了为准备和减少动物源溢出事件的发生频率并将新爆发的风险降至最低而制定的策略。